Completed
Vorinostat and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
NCT00310024
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
- Locations
-
- University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States